Network origin in Benoît Flamant first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
IT Asset Management SA
 IT Asset Management SA Investment ManagersFinance IT Asset Management SA (ITAM), established in 1994, is an independent asset management firm based in Paris, France. ITAM is wholly-owned by their management and employees. The firm provides financial advisory services and manages discretionary portfolios and mutual funds (FCPs and a compartment of a Luxembourg-based SICAV) for institutional clients and private individuals.
7
| Extinct | Investment Managers | 7 |
COGES Corraterie Gestion SA
 COGES Corraterie Gestion SA Investment ManagersFinance COGES Corraterie Gestion SA is the wealth management subsidiary of Banque Baring Bros. Sturdza SA in Switzerland. Headquartered in Geneva, the firm was founded in 1984 and provides a wide range of services encompassing all dimensions of wealth management and integrating client’s financial, family and professional requirements. They build bespoke portfolios and offer tailored investment advice to private wealthy clients.
3
| Subsidiary | Investment Managers | 3 |
Finaltis SA
 Finaltis SA Investment ManagersFinance Finaltis SA is an alternative investment management firm headquartered in Paris, France. It was founded by Denis Beaudoin in 2001 and is a subsidiary of Finaltis SAS. The firm offers alternative investment solutions to institutional and private clients. Finaltis is a signatory of the United Nations Principles for Responsible Investment (UNPRI).
1
| Subsidiary | Investment Managers | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Benoît Flamant via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| 4SC AG | Biotechnology | Chief Executive Officer | |
Crédit Mutuel Asset Management SA
 Crédit Mutuel Asset Management SA Investment ManagersFinance Crédit Mutuel Asset Management SA (CM-AM) is an asset management firm headquartered in Paris, France. The firm was founded in 1992 and is a subsidiary of Groupe Crédit Mutuel Centre Est Europe SA, ultimately held by Confederation Nationale Crédit Mutuel SA. CM-AM offers a complete range of funds to various investors. | Investment Managers | Portfolio Manager-Equities Portfolio Manager-Equities | |
| University of Adelaide | College/University | Doctorate Degree | |
| RESONANCE HEALTH LIMITED | Medical/Nursing Services | Director/Board Member | |
| Korda & Co. | Investment Managers | Chief Investment Officer | |
| The University of New South Wales | College/University | Undergraduate Degree | |
| BIOFRONTERA AG | Pharmaceuticals: Major | Director/Board Member | |
| ACTINOGEN MEDICAL LIMITED | Pharmaceuticals: Other | Chairman | |
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chief Executive Officer | |
Iris Finance SA
 Iris Finance SA Investment ManagersFinance Iris Finance SA is a French company that creates investment solutions specifically designed to protect and enhance clients' wealth. Iris Finance is based in Paris, FR and provides an overview of its subsidiaries' activities, economic trends, and market news through press releases and communications. The private company offers sustainable and high-value solutions to non-professional and eligible professional clients. The company was founded in 1994. | Investment Managers | Chief Executive Officer | |
Dôm Finance SAS
 Dôm Finance SAS Investment ManagersFinance Dôm Finance SAS is an independent French asset management firm headquartered in Paris. The firm was founded by Philippe Douillet and Eric Marmousez in 2004. Dôm Finance manages investment vehicles for institutional and private clients. The firm is a signatory to the Carbon Disclosure Project, a non-profit NGO that publicly reports environmental data on more than 2500 issuers. | Investment Managers | Portfolio Manager-Equities | |
Parvulus Suisse SA
 Parvulus Suisse SA Medical SpecialtiesHealth Technology Parvulus Suisse SA provides medical technology. It focused on commercializing devices for cardiac surgery distribution, manufacturing, sales and distribution. The company was founded in March 20011 and is headquartered in Lonay, Switzerland. | Medical Specialties | Chief Executive Officer | |
FOURPOINTS Investment Managers SAS
 FOURPOINTS Investment Managers SAS Investment ManagersFinance FOURPOINTS Investment Managers SAS (FOURPOINTS) is an investment management subsidiary of Homa Capital SA in France. The firm was founded by Béatrice Philippe in 2012 when PIM Gestion France and IT Asset Management merged. Headquartered in Paris, FOURPOINTS offers investment solutions for retail, institutional and CGPI clients. It is available through a wide variety of management methods: management under mandate, managed management, equity funds and diversified funds of funds. | Investment Managers | Chief Executive Officer Analyst-Equity Head-Equity Investments Analyst-Equity Sales & Marketing | |
| Warambi SARL | Director/Board Member | ||
| JDS BioPharma Pty Ltd. | Director/Board Member | ||
Corticrine Ltd.
 Corticrine Ltd. Pharmaceuticals: MajorHealth Technology Part of Actinogen Medical Ltd., Corticrine Ltd. develops and manufactures drugs. The company is based in Edinburgh, UK. Corticrine was acquired by Actinogen Medical Ltd. on December 01, 2014 for $4.97 million. | Pharmaceuticals: Major | Director/Board Member | |
Tirawa SA
 Tirawa SA Other Consumer ServicesConsumer Services Tirawa SA provides tours and travelling services. The private company is based in Montmelian, France. Christian Juni has been the CEO of the French company since 2018. | Other Consumer Services | Director/Board Member | |
| INVEX THERAPEUTICS LTD | Biotechnology | Founder | |
| Warambi Ltd. | Corporate Officer/Principal | ||
| Invex Therapeutics Ltd. (United Kingdom) | Director/Board Member |
Statistics
International
| France | 11 |
| United Kingdom | 7 |
| Australia | 7 |
| Germany | 3 |
| Ireland | 2 |
Sectoral
| Health Technology | 10 |
| Finance | 8 |
| Consumer Services | 4 |
| Health Services | 2 |
| Commercial Services | 2 |
Operational
| Portfolio Manager-Equities | 17 |
| Director/Board Member | 14 |
| Chief Executive Officer | 8 |
| Analyst-Equity | 5 |
| Corporate Officer/Principal | 4 |
Most connected contacts
- Stock Market
- Insiders
- Benoît Flamant
- Company connections
